SCHEMBL3850124

SCHEMBL3850124

O=C(O)CCCCCCOc1ccc(-c2cnc3ccc(-c4c[nH]nc4-c4ccc(F)cc4)cn23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.39
FABP4 P15090 5/20 0.39
FABP3 P05413 3/20 0.39
FFAR4 Q5NUL3 4/20 0.37
CLK1 P49759 1/20 0.37
DYRK1A Q13627 1/20 0.37
DGAT1 O75907 1/20 0.37
FFAR1 O14842 1/20 0.37
FLT3 P36888 1/20 0.36
HDAC3 O15379 5/20 0.36
HDAC4 P56524 5/20 0.36
HDAC1 Q13547 5/20 0.36
HDAC7 Q8WUI4 5/20 0.36
HDAC2 Q92769 5/20 0.36
HDAC10 Q969S8 5/20 0.36
HDAC11 Q96DB2 5/20 0.36
HDAC8 Q9BY41 5/20 0.36
HDAC6 Q9UBN7 5/20 0.36
HDAC9 Q9UKV0 5/20 0.36
HDAC5 Q9UQL6 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846673 0.89 FAAH (0.43) CLK1DYRK1A
SCHEMBL3851968 0.85 FLT3 (0.40) CLK1DYRK1AFLT3
SCHEMBL3847437 0.84 L3MBTL1 (0.40) CLK1DYRK1AFLT3
SCHEMBL13874137 0.83 FLT3 (0.51) CLK1DYRK1AFLT3
SCHEMBL3849735 0.82 CLK1 (0.38) CLK1DYRK1AFLT3
Hydrochloric Acid SCHEMBL3856691 0.82 FLT3 (0.50) CLK1DYRK1AFLT3
Hydrochloric Acid SCHEMBL3845911 0.81 GABRA1 (0.41) CLK1DYRK1AFLT3
Hydrochloric Acid SCHEMBL3854393 0.81 FLT3 (0.42) FLT3
SCHEMBL14145573 0.80 LTB4R (0.38) LTB4RFABP4FABP3CLK1DYRK1A
SCHEMBL3847634 0.80 FLT3 (0.46) CLK1DYRK1AFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed